Status:
COMPLETED
PR-VR At-home Program During and After COVID-19
Lead Sponsor:
The Hospital for Sick Children
Collaborating Sponsors:
Stanford University
Conditions:
Pain, Chronic
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
Poorly controlled chronic pain in teens can impact quality of life, increase opioid use and is a risk factor for developing chronic pain in adulthood. Currently, there is a shortage of support to help...
Detailed Description
Chronic pain affects the lives of 1 in 5 - or 2 million - Canadian children and adolescents and has negative impacts on all aspects of health-related quality of life as well as significant economic co...
Eligibility Criteria
Inclusion
- able to speak and read English,
- 12-18 years old,
- diagnosed with chronic pain,
- under active care at the interprofessional out-patient Chronic Pain Clinic at SickKids,
- on stabilized medication/therapy (no new pain medications/therapies for 1 week prior to the initial PT assessment and treatment) according to medical chart,
- independently mobile and able to safely engage in physical activity,
- requiring a minimum of 4 treatments (1-hour sessions of virtual PT) typically once per week,
- able to have access to an Internet-enabled smartphone, computer or tablet at home (typically once per week for 4 weeks) according to self-report for Zoom for Healthcare visits with PT, and
- willing to have Zoom for Healthcare visits with PT recorded during the study period and, if selected, individual telephone interview with research assistant (RA) audio recorded following the study period.
Exclusion
- visual, auditory or cognitive impairments precluding interaction with the PR-VR intervention and/or control equipment (Internet) as assessed by reviewing the patient's medical chart and consultation with the patient's PT.
- diagnosis of seizure disorder, history of seizure, or increased risk of seizure.
- new onset of headaches/migraines, motion sickness, nausea or vomiting or history/symptoms of possible concussion.
- diagnosis of major, untreated, concurrent psychiatric illness (e.g., depression, anxiety, conversion disorder, PTSD) or personality disorder as assessed by reviewing the patient's medical chart and in consultation by their health care team.
- currently receiving sedating medications
- claustrophobia or previous intolerance of virtual reality (e.g. nausea, vomiting, motion sickness, eye strain, false memory formation) as assessed by health care team.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 6 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04912817
Start Date
September 1 2022
End Date
December 6 2024
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Sick Children
Toronto, Ontario, Canada, m5g 1x8